Synthetic Biologics' investor relations mobile iPhone App, called the “SYN IR” App is available for free at the Apple App Store on the iPhone or iPad or at http://bit.ly/I9xDpW.
Jeff Riley, Synthetic Biologics' Chairman and CEO, will present at the ROTH Capital Partners 24th Annual Growth Stock Conference being held at The Ritz-Carlton in Dana Point, CA from March 11 through March 14, 2012.
A live webcast of Synthetic Biologics’ presentation can be accessed by logging onto the web at http://wsw.com/webcast/roth26/syn/. After the presentation, a replay will be archived and accessible for 14 days at the same website.
For more information about the conference, please click here.
Jeff Riley, the Company's Chief Executive Officer and Chairman, will be the featured presenter at the upcoming Harvard Investors Group forum. Mr. Riley will provide an overview of the Company's synthetic biologics program, its collaboration with Intrexon Corporation for pulmonary arterial hypertension and its funded clinical trial programs at the invitation-only dinner event on Monday evening, February 13, 2012, at The Manhattan Club in New York City.
Adeona intends to file the slide deck used at the Harvard Investors Group forum in a Current Report on Form 8-K with the Securities & Exchange Commission, concurrent with its presentation on Monday, February 13, 2102.
